Pediatric Advisory Subcommittee meeting
Executive Summary
The Pediatric Advisory Subcommittee of the Anti-Infective Drugs Advisory Committee will meet in June to discuss Subpart D issues associated with the approval of institutional review boards for at least three drugs. Subpart D, which FDA adopted in April 2001, provides safeguards for children in clinical trials...